Investment Rating - The report maintains an "Overweight" rating for the computer industry [1] Core Insights - The brain-computer interface (BCI) technology is a key focus in the "14th Five-Year Plan," with continuous technological breakthroughs expected [1][4] - The market for brain-computer interfaces in China is projected to grow from 3.2 billion yuan in 2024 to 6.14 billion yuan by 2028, indicating a broad market potential [11][12] - The report highlights significant policy support and the establishment of standards for BCI technology, which will facilitate its integration into the healthcare system [9][10][12] Summary by Sections 1. Policy and Industry Development - Frequent policies are promoting the standardization and development of the BCI industry, with the National Development and Reform Commission listing BCI as one of the ten iconic products for future industries [9] - The National Medical Insurance Administration's announcement in September 2025 aims to expedite the approval process for innovative medical consumables, including BCIs, facilitating their entry into hospitals [10] 2. Technological Breakthroughs - Clinical trials for invasive BCIs have been conducted in major hospitals, with over 30 experiments related to spinal cord injuries and ALS patients [13] - Non-invasive BCI products are gaining regulatory approval, with companies like Shaonao Technology and Aipeng Medical making significant strides in commercialization [16][19] 3. Investment Recommendations - The report suggests focusing on companies actively involved in the BCI sector, including Innovation Medical, Chengyitong, Sanbo Brain Science, and others, due to the accelerating clinical and commercial progress [21]